American Financial Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

American Financial Group’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-158,850	Closed	-$969K	–	98
2021 Q3	$969K	Hold	158,850	–	–	0.26%	58
2021 Q2	$1.31M	Hold	158,850	–	–	0.33%	55
2021 Q1	$1.42M	Sell	158,850 -158,850	-50%	-$1.82M	0.24%	57
2020 Q4	$3.67M	Hold	317,700	–	–	0.47%	50
2020 Q3	$3.31M	Hold	317,700	–	–	0.46%	46
2020 Q2	$4.18M	Hold	317,700	–	–	0.56%	50
2020 Q1	$2.5M	Hold	317,700	–	–	0.3%	70
2019 Q4	$6.58M	Hold	317,700	–	–	0.57%	48
2019 Q3	$4.35M	Hold	317,700	–	–	0.36%	65
2019 Q2	$3.91M	Hold	317,700	–	–	0.32%	67
2019 Q1	$3.96M	Hold	317,700	–	–	0.35%	63
2018 Q4	$3.6M	Hold	317,700	–	–	0.34%	73
2018 Q3	$5.94M	Hold	317,700	–	–	0.59%	53
2018 Q2	$8.21M	Hold	317,700	–	–	0.79%	42
2018 Q1	$7.12M	Buy	317,700 +106,800	+51%	+$2.61M	0.68%	51
2017 Q4	$5.28M	Buy	+210,900	New	+$5.16M	0.56%	54

American Financial Group's FLXN Position: Q4 2021 in Review

American Financial Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 158,850 shares — an estimated $969K sold.

American Financial Group first reported a position in FLXN in Q4 2017 and held it in 16 quarters. The position peaked at $8.21M in Q2 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

American Financial Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
American Financial Group sold 158,850 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $969K.
American Financial Group first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 16 quarters.
American Financial Group's Flexion Therapeutics, Inc. position peaked at $8.21M in Q2 2018.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on American Financial Group's 13F filing for Q4 2021, filed 10 Feb 2022.